Jiming Huang / Perfil

October 2019 marked a milestone for modern genetic medicine. A leading Swiss drug maker registered USD 160 million of quarterly sales for the world's most expensive drug – Zolgensma – a gene therapy priced at USD 2.1 million...

Impeachment. The House Intelligence Committee held more closed hearings this week as part of the ongoing impeachment inquiry. The process will move to a more public phase next week when the committee initiates open hearings that will feature witnesses who have already testified privately...

Pivot (invalidation): 56.65 Our preference Long positions above 56.65 with targets at 57.15 & 57.45 in extension. Alternative scenario...

Pivot (invalidation): 16.7500 Our preference Long positions above 16.7500 with targets at 16.9800 & 17.0900 in extension. Alternative scenario...

Pivot (invalidation): 1459.00 Our preference Long positions above 1459.00 with targets at 1468.00 & 1472.50 in extension. Alternative scenario...

Pivot (invalidation): 3080.00 Our preference Long positions above 3080.00 with targets at 3098.00 & 3109.00 in extension. Alternative scenario...

Pivot (invalidation): 13270.00 Our preference Short positions below 13270.00 with targets at 13180.00 & 13120.00 in extension...

Pivot (invalidation): 5.7580 Our preference Long positions above 5.7580 with targets at 5.7765 & 5.7860 in extension. Alternative scenario...

Pivot (invalidation): 0.6870 Our preference Short positions below 0.6870 with targets at 0.6845 & 0.6830 in extension. Alternative scenario...

Pivot (invalidation): 1.3205 Our preference Long positions above 1.3205 with targets at 1.3240 & 1.3260 in extension. Alternative scenario...

Pivot (invalidation): 0.9955 Our preference Long positions above 0.9955 with targets at 0.9980 & 1.0000 in extension. Alternative scenario...

Pivot (invalidation): 109.20 Our preference Short positions below 109.20 with targets at 108.90 & 108.75 in extension. Alternative scenario...

Pivot (invalidation): 1.2805 Our preference Short positions below 1.2805 with targets at 1.2780 & 1.2765 in extension. Alternative scenario...

Pivot (invalidation): 1.1030 Our preference Short positions below 1.1030 with targets at 1.1015 & 1.1000 in extension. Alternative scenario...

A number of points remain to be clarified. Which tariffs would be canceled, when, and subject to what conditions still need to be negotiated. As of time of writing, US officials have yet to confirm the Chinese Commerce Ministry remarks...

Although it should stay in the background looking forward, the Bank of England monetary policy meeting already provided solid arguments that rate cuts could be explored in 2020 as the central bank is becoming more and more dovish in the midst of headwinds from both Brexit, the global economy and...

Pivot (invalidation): 56.80 Our preference Long positions above 56.80 with targets at 57.20 & 57.55 in extension. Alternative scenario...

Pivot (invalidation): 17.1500 Our preference Short positions below 17.1500 with targets at 16.9300 & 16.7800 in extension. Alternative scenario...

Pivot (invalidation): 1479.00 Our preference Short positions below 1479.00 with targets at 1460.00 & 1452.00 in extension. Alternative scenario...

Pivot (invalidation): 3098.00 Our preference Short positions below 3098.00 with targets at 3076.00 & 3065.00 in extension. Alternative scenario...